eXTReMe Tracker
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter September 2010

Gene Therapy Net Banner
News: Journal of Gene Medicine online-only
The Wiley-Blackwell publication Journal of Gene Medicine will be going online-only commencing January 2011. Authors submitting to this online-only title can take advantage of additional benefits such as:
  • No charges for colour figures
  • Faster issue publication times
  • Better integration of online supporting information for articles

  • Click here to submit your next article online. To find out more about Journal of Gene Medicine visit the homepage: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-2254

    Read more...

    News: Gene Doping Detectable With a Simple Blood Test
    German scientists from Tübingen and Mainz have developed a blood test that can reliably detect gene doping even after 56 days. Scientists at the universities in Tübingen and Mainz have developed a test that can provide conclusive proof of gene doping. "For the first time, a direct method is now available that uses conventional blood samples to detect doping via gene transfer and is still effective if the actual doping took place up to 56 days before," Professor Perikles Simon, MD, PhD from Johannes Gutenberg University Mainz, Germany explained. "This represents a relatively low-cost method of detecting several of the most common doping genes," Simon stated in the presentation of the process.
    Read more...

    News: Public Workshop on Cell and Gene Therapy Clinical Trials in Pediatric Populations
    The FDA will convene a one-day workshop (November 2, 2010 - 8:00 AM-5:30 PM) to facilitate an exchange of information about best practices in conducting cell and gene therapy clinical trials in pediatric populations. Cellular and gene therapies are the subject of great interest as novel products that potentially may improve the lives of patients by restoring lost function and modifying the nature and course of diseases. However, these therapies are not without risks: indeed, the novelty of these products contributes to their real and potential risks. Conducting clinical trials with novel products in pediatric patients requires special scrutiny to ensure that the rights of subjects are protected and that potential risks and benefits are appropriately balanced.
    The purpose of the workshop is to gather information from Institutional Review Boards (IRBs), gene and cellular therapy clinical researchers, and other stakeholders regarding best practices related to cell and gene therapy clinical trials in pediatric populations, as well as challenges and considerations in the review of these clinical trials.

    Read more...

    News: New Hope Against Melanoma
    By taking a different approach, scientists have developed the next promising cancer treatment: targeted gene therapy. Skin cancer is scary, and it's tricky. If caught early it is easily treatable, but if not, it's potentially deadly. Even the best dermatologists can't spot everything. Targeted gene therapy is the latest treatment recognized by the New England Journal of Medicine. The new approach is proving fruitful when it comes to patients with the deadliest form of skin cancer: metastasized melanoma.
    Read more...

    News: Gene Therapy to Treat Epilepsy a Step Closer
    Current antiepileptic drugs (AEDs) have many side-effects, among others slowing down brain activity, which in turn reduces patients' ability to react. These side-effects could be eliminated if genes that counteract seizures could be introduced into the brain. Professor Merab Kokaia at Lund University in Sweden has obtained promising results in animal experiments.
    Read more...

    Conferences
    - 24 - 27 September 2010, Cellular Therapy of Cancer Symposium - ATTACK Project Meeting, Montpellier, France
    - 6 - 9 October 2010, 17th Annual Meeting German Society for Gene Therapy (DG-GT e.V.), Munich, LMU Campus Grosshadern, Germany
    - 22 - 25 October 2010, European Society of Gene and Cell Therapy (ESGCT) 18th Annual Congress, Milan, Italy
    - 2 November 2010, FDA Public Workshop on Cell and Gene Therapy Clinical Trials in Pediatric Populations, North Bethesda, MD
    - 16 November 2010, 3rd annual Workshop on Genome Engineering, Seattle, WA
    - 17 - 19 November 2010, 9th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases. Focus Topic: Gene Expression, Sonoma, CA
    - 19 November 2010, 4th Annual Conference of the Korea Society of Gene Therapy (KSGT), Seoul, Korea
    - 20 January 2011, COGEM Symposium: GM viruses as medicine: panacea or pandora's box?, Amsterdam, The Netherlands
    - 24 - 26 January 2011, Phacilitate 7th Annual Cell & Gene Therapy Forum 2011, Washington DC, MD
    - 10 - 11 March 2011, Spring Meeting of the Dutch Society of Gene Therapy (NVGT), Heeze, The Netherlands
    - 16 - 19 March 2011, 6th International Conference on Oncolytic Viruses as Cancer Therapeutics, Las Vegas, NV
    - 4 - 6 May 2011, Australasian Gene Therapy Society (AGTS) 7th Meeting, Melbourne, Australia
    - 18 - 21 May 2011, International Society for Cellular Therapy (ISCT) 17th Annual Meeting, Rotterdam, The Netherlands
    - 18 - 22 May 2011, American Society of Gene and Cell Therapy (ASGCT) 14th Annual Meeting, Seattle, WA
    - 29 May - 2 June 2011, Gordon Research Conference: Virusses & Cells, Lucca (Barga), Italy
    - 15 – 17 July 2011, The 17th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Kyushu University, Fukuoka, Japan
    - 27 - 31 October 2011, British Society of Gene Therapy (BSGT) 8th Annual Conference, Brighton, UK

    Read more...

    Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines, www.genetherapynet.com
    To unsubscribe from the Newsletter, please login and edit your subscription details or contact us